BioMarin Pharmaceutical Company Profile (NASDAQ:BMRN)

Analyst Ratings

Consensus Ratings for BioMarin Pharmaceutical (NASDAQ:BMRN) (?)
Ratings Breakdown: 2 Hold Rating(s), 18 Buy Rating(s)
Consensus Rating:Buy (Score: 2.90)
Consensus Price Target: $124.53 (33.07% upside)

Analysts' Ratings History for BioMarin Pharmaceutical (NASDAQ:BMRN)
Show:
DateFirmActionRatingPrice TargetActions
6/22/2016Leerink SwannReiterated RatingOutperform$107.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/20/2016Oppenheimer Holdings Inc.Reiterated RatingMarket Perform$99.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/16/2016Barclays PLCReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/13/2016Credit Suisse Group AGReiterated RatingBuy$103.00 -> $114.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2016Goldman Sachs Group Inc.Reiterated RatingBuy$126.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/31/2016Royal Bank Of CanadaReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2016Cowen and CompanyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/20/2016Piper Jaffray Cos.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/19/2016WedbushReiterated RatingNeutral$108.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/8/2016Jefferies GroupReiterated RatingBuy$120.00 -> $116.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/7/2016BMO Capital MarketsInitiated CoverageOutperform$99.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/22/2016William BlairReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/8/2016Robert W. BairdInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/8/2016JPMorgan Chase & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2016Stifel NicolausBoost Price TargetBuy$105.00 -> $107.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/15/2016Bank of America Corp.Reiterated RatingBuy$165.00 -> $135.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/13/2015Raymond James Financial Inc.Reiterated RatingOutperform$157.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/6/2015Deutsche Bank AGReiterated RatingBuy$160.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/4/2015Nomura Holdings Inc.Reiterated RatingBuy$163.00 -> $173.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/4/2015SunTrust Banks Inc.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/18/2015Canaccord GenuityBoost Price TargetBuy$115.00 -> $150.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2015Brean CapitalReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2015Citigroup Inc.Reiterated RatingBuy$94.00 -> $133.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2015Evercore ISIInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/3/2014Wells Fargo & Co.UpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/23/2014 forward)

Earnings

Earnings History for BioMarin Pharmaceutical (NASDAQ:BMRN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/1/2016        
4/28/2016Q116($0.85)($0.53)$240.21 million$236.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2016Q415$0.67$0.39$224.14 million$227.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2015Q315($0.65)($0.60)$216.32 million$208.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/3/2015Q215($0.53)($0.51)$218.16 million$250.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2015Q1($0.53)($0.43)$201.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2015Q414($0.59)($0.47)$189.01 million$230.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/23/2014Q314($0.22)($0.16)$206.00 million$176.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2014Q214($0.41)($0.23)$159.70 million$191.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2014($0.44)($0.01)$145.16 million$151.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2014Q413($0.35)($0.11)$146.07 million$146.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/24/2013Q313($0.30)($0.38)$140.00 million$136.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/25/2013Q2 2013($0.29)($0.16)$134.33 million$136.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/25/2013Q1 2013($0.30)($0.31)$131.35 million$127.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/21/2013Q4 2012($0.22)($0.43)$129.70 million$130.96 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/25/2012($0.20)($0.04)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2012($0.19)($0.27)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/26/2012($0.15)($0.21)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/16/2012($0.10)($0.23)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2011($0.10)($0.16)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/28/2011($0.09)($0.05)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/28/2011($0.10)$0.14ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/17/2011($0.02)($0.11)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for BioMarin Pharmaceutical (NASDAQ:BMRN)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20166($2.51)($0.40)($0.94)
Q2 20166($4.02)($0.27)($2.11)
Q3 20166($0.63)($0.24)($0.46)
Q4 20165($0.67)($0.26)($0.53)
Q1 20171($0.48)($0.48)($0.48)
Q2 20171($0.28)($0.28)($0.28)
Q3 20171($0.31)($0.31)($0.31)
Q4 20171($0.25)($0.25)($0.25)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for BioMarin Pharmaceutical (NASDAQ:BMRN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for BioMarin Pharmaceutical (NASDAQ:BMRN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
7/18/2016Jean Jacques BienaimeCEOSell41,666$92.72$3,863,271.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/7/2016George Eric DavisEVPSell2,167$90.00$195,030.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/20/2016V Bryan LawlisDirectorSell550$82.77$45,523.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2016Jean Jacques BienaimeCEOSell41,666$80.55$3,356,196.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/6/2016Daniel K SpiegelmanCFOSell1,649$89.14$146,991.86View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/31/2016Daniel K SpiegelmanCFOSell20,841$89.88$1,873,189.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/26/2016Henry J FuchsEVPSell15,000$87.81$1,317,150.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/23/2016Daniel K SpiegelmanCFOSell3,769$87.07$328,166.83View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/18/2016Robert BaffiEVPSell5,000$87.05$435,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/10/2016George Eric DavisEVPSell14,658$85.11$1,247,542.38View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/5/2016Jean Jacques BienaimeCEOSell50,000$80.15$4,007,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/3/2016Jeffrey Robert AjerEVPSell415$86.03$35,702.45View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/2/2016Jean Jacques BienaimeCEOSell36,500$85.01$3,102,865.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/14/2016George Eric DavisEVPSell1,996$86.21$172,075.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/4/2016Jeffrey Robert AjerSVPSell1,255$88.42$110,967.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2016Daniel K SpiegelmanCFOSell4,623$86.12$398,132.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/1/2016Jean Jacques BienaimeCEOSell10,000$84.28$842,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/22/2016Michael G GreyDirectorSell7,500$80.00$600,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/16/2015George Eric DavisSVPSell1,362$100.00$136,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/30/2015Jean Jacques BienaimeCEOSell1,000$94.74$94,740.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/16/2015Daniel K. SpiegelmanCFOSell20,000$104.30$2,086,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/16/2015V Bryan LawlisDirectorSell8,550$106.90$913,995.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/15/2015Jean Jacques BienaimeCEOSell1,000$108.24$108,240.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/14/2015Jean Jacques BienaimeCEOSell1,000$131.43$131,430.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/20/2015Jeffrey Robert AjerSVPSell3,000$150.00$450,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/7/2015Jean Jacques BienaimeCEOSell1,500$139.07$208,605.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2015Daniel K SpiegelmanCFOSell1,649$122.30$201,672.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2015Henry J FuchsEVPSell1,864$122.32$228,004.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2015Jeffrey Robert AjerSVPSell1,362$122.35$166,640.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2015Daniel K SpiegelmanCFOSell5,523$124.73$688,883.79View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2015Jeffrey Robert AjerSVPSell377$123.76$46,657.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/29/2015Daniel K SpiegelmanCFOSell1,578$126.15$199,064.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/26/2015Jeffrey Robert AjerSVPSell1,625$126.55$205,643.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/18/2015Daniel K SpiegelmanCFOSell2,059$124.77$256,901.43View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/18/2015George Eric DavisSVPSell2,558$125.26$320,415.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/18/2015Henry J FuchsEVPSell1,864$124.78$232,589.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2015Henry J FuchsEVPSell1,434$121.37$174,044.58View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/11/2015Henry J FuchsEVPSell2,869$121.64$348,985.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/17/2015Jean Jacques BienaimeCEOSell2,000$124.17$248,340.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/16/2015Henry J FuchsEVPSell41,315$123.57$5,105,294.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/16/2015Jean Jacques BienaimeCEOSell1,000$123.48$123,480.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2015Jean Jacques BienaimeCEOSell21,021$112.39$2,362,550.19View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/9/2015Jean Jacques BienaimeCEOSell19,000$112.13$2,130,470.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/5/2015Jean Jacques BienaimeCEOSell10,000$113.70$1,137,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/5/2015Robert BaffiEVPSell14,051$116.37$1,635,114.87View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/4/2015Jean Jacques BienaimeCEOSell13,916$107.92$1,501,814.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2015Jean Jacques BienaimeCEOSell5,000$107.42$537,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015Daniel K SpiegelmanCFOSell15,500$107.00$1,658,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015George Eric DavisSVPSell23,000$108.31$2,491,130.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015Jean Jacques BienaimeCEOSell5,000$108.44$542,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/9/2015Jean Jacques BienaimeCEOSell2,000$94.14$188,280.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/24/2014Jean Jacques BienaimeCEOSell5,000$88.73$443,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/10/2014Jean Jacques BienaimeCEOSell2,000$95.00$190,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/4/2014Alan LewisDirectorSell7,500$89.90$674,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/2/2014Brian MuellerVPSell11,950$90.91$1,086,374.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/25/2014George Eric DavisSVPSell20,000$89.75$1,795,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/25/2014Jean Jacques BienaimeCEOSell2,000$90.00$180,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2014Jean Jacques BienaimeCEOSell1,000$81.51$81,510.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2014Henry J FuchsEVPSell20,000$86.55$1,731,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2014Jean Jacques BienaimeCEOSell4,000$87.00$348,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Jean Jacques BienaimeCEOSell3,000$85.33$255,990.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Jeffrey Robert AjerSVPSell47$83.54$3,926.38View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/30/2014Robert BaffiEVPSell75,425$81.34$6,135,069.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/24/2014Jean Jacques BienaimeCEOSell2,000$80.00$160,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/19/2014George Eric DavisSVPSell17,536$69.75$1,223,136.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2014Daniel K SpiegelmanCFOSell16,000$69.83$1,117,280.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/20/2014Jean Jacques BienaimeCEOSell5,000$70.00$350,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/5/2014Henry J FuchsEVPSell10,000$65.00$650,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2014Daniel K SpiegelmanCFOSell2,229$61.76$137,663.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/2/2014Daniel K SpiegelmanCFOSell2,229$64.00$142,656.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2014Jean Jacques BienaimeCEOSell2,000$61.20$122,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/22/2014Jean Jacques BienaimeCEOSell1,000$56.88$56,880.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/21/2014Jean Jacques BienaimeCEOSell1,545$56.19$86,813.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2014Henry FuchsEVPSell1,864$56.86$105,987.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2014Jeffrey Robert AjerSVPSell1,004$56.91$57,137.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2014V Bryan LawlisDirectorSell1,700$56.87$96,679.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2014Henry FuchsEVPSell1,434$58.23$83,501.82View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2014Henry FuchsEVPSell3,479$57.91$201,468.89View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2014Henry FuchsEVPSell10,000$67.70$677,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/24/2013Jean Jacques BienaimeCEOSell10,000$68.71$687,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/5/2013Jean Jacques BienaimeCEOSell5,000$69.70$348,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/16/2013Jean Jacques BienaimeCEOSell2,000$67.73$135,460.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/10/2013Jean Jacques BienaimeCEOSell3,000$66.76$200,280.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/19/2013Henry FuchsEVPSell10,000$80.19$801,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2013Jean Jacques BienaimeCEOSell2,000$73.08$146,160.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/9/2013Robert BaffiEVPSell20,000$73.00$1,460,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/5/2013Henry J FuchsEVPSell10,000$70.00$700,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2013Daniel K SpiegelmanCFOSell9,000$69.00$621,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/15/2013Jean Jacques BienaimeCEOSell1,000$64.36$64,360.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2013Daniel K SpiegelmanCFOSell4,066$59.78$243,065.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2013Henry J FuchsEVPSell10,000$60.00$600,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2013Henry J FuchsEVPSell1,098$58.32$64,035.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/23/2013Henry J FuchsEVPSell20,609$66.29$1,366,170.61View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/22/2013Mark WoodVPSell3,103$67.12$208,273.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/21/2013Jean Jacques BienaimeCEOSell2,000$64.14$128,280.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2013Jean Jacques BienaimeCEOSell12,000$67.90$814,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2013Brian MuellerVPSell4,947$70.35$348,021.45View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2013George Eric DavisSVPSell20,000$70.34$1,406,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2013Jean Jacques BienaimeCEOSell15,000$70.17$1,052,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2013Jean Jacques BienaimeCEOSell15,800$68.77$1,086,566.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2013Jeffrey Robert AjerSVPSell1,248$69.26$86,436.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/8/2013Jean Jacques BienaimeCEOSell4,000$65.87$263,480.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/2/2013Jean Jacques BienaimeCEOSell3,000$64.99$194,970.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/10/2013Robert BaffiEVPSell20,000$64.00$1,280,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/22/2013Mark WoodVPSell3,103$60.21$186,831.63View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/4/2013George Eric DavisSVPSell4,000$60.18$240,720.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/22/2013Mark WoodVPSell3,103$55.22$171,347.66View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2013Jean Jacques BienaimeCEOSell2,000$55.77$111,540.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/27/2012Jean Jacques BienaimeCEOSell17,000$48.37$822,290.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2012George Eric DavisSVPSell99,075$48.45$4,800,183.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2012Henry J FuchsEVPSell5,000$37.76$188,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/22/2012Mark WoodVPSell2,665$37.93$101,083.45View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for BioMarin Pharmaceutical (NASDAQ:BMRN)
DateHeadline
07/23/16 02:50 PMStock Up Nicely This Week: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - TGP
07/21/16 03:03 PMBioMarin to Provide Updated Data for BMN 270 in Hemophilia A in Late Breaking Oral Presentation at the World Federation of Hemophilia (WFH) 2016 World Congress July 27th - [GlobeNewswire] - SAN RAFAEL, Calif., July 21, 2016-- BioMarin Pharmaceutical Inc. announced today that interim results of an open-label, Phase 1/ 2 study of BMN 270, an AAV5-FVIII Gene transfer in severe Hemophilia will ...
07/21/16 11:24 AMChief Executive Officer of BioMarin Pharmaceutical Inc (NASDAQ:BMRN), Bienaime Jean Jacques, sells 41,666 shares worth $3,863,272
07/20/16 09:47 PMInsiders Selling, Short Interest Growing BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
07/20/16 03:25 PMPerformance to see: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - News Oracle
07/19/16 11:06 AMWhat Are Roche’s Truest Growth Opportunities? -
07/19/16 09:04 AMBiotech Stocks Worth a Closer Look: Opko Health (NASDAQ:OPK), BioMarin Pharmaceutical (NASDAQ:BMRN) - The Voice Registrar
07/19/16 09:04 AMMost recent Analysts Rating report: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) , Halozyme Therapeutics, Inc ... - Street Updates
07/19/16 09:04 AMTarget Corporation (NYSE:TGT) & BioMarin Pharmaceutical (NASDAQ:BMRN) Stocks to Watch - Money News (press release)
07/19/16 08:52 AMCan The Uptrend Continue for with BioMarin Pharmaceutical (BMRN)? -
07/19/16 05:04 AMBIOMARIN PHARMACEUTICAL INC Files SEC form 8-K, Change in Directors or Principal Officers -
07/18/16 02:59 PMBioMarin Pharma (BMRN) Names Two New Board Members - StreetInsider.com
07/18/16 02:59 PMTrading the Biotech News: Navidea Biopharmaceuticals, Inc (NYSEMKT:NAVB), BioMarin Pharmaceutical Inc ... - The Voice Registrar
07/18/16 02:59 PMAnalyst Recommendations Watch: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - News Oracle
07/18/16 10:52 AMSeptember 16th Options Now Available For BioMarin Pharmaceutical (BMRN) - Investors in BioMarin Pharmaceutical Inc. (NASD: BMRN) saw new options begin trading today, for the September 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BMRN options chain for the new September 16th contracts and identified one put and one call contract of particular interest.
07/18/16 07:52 AMAnalysts Are Expecting this Stock to Rise: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - TGP
07/18/16 07:52 AMSummary of Analyst's Study: Johnson & Johnson (NYSE:JNJ) , BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - Street Updates
07/18/16 07:51 AMHC Stocks Analysis: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Immune Pharmaceuticals Inc (NASDAQ:IMNP) - share market updates (press release)
07/18/16 07:31 AMBioMarin Appoints Two BioPharmaceutical Veterans to Board of Directors, Willard Dere, M.D. and Kathryn E. Falberg - [GlobeNewswire] - SAN RAFAEL, Calif., July 18, 2016-- BioMarin Pharmaceutical Inc., a global leader in providing therapies for rare genetic diseases, today announced the appointment of two biopharmaceutical veterans to ...
07/17/16 02:45 PMBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) from Biotechnology – Todays Top Gains - Twin County News
07/17/16 02:45 PMNext Weeks Broker Price Targets For BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - Fiscal Standard
07/16/16 02:51 PMShare Performance Summary for: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - Press Telegraph
07/15/16 01:28 PMTime To Put On The Watch List? - XBiotech (NASDAQ:XBIT), BioMarin Pharmaceutical (NASDAQ:BMRN) - The Voice Registrar
07/14/16 11:34 AMBiotech Stocks Worth a Closer Look: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Mast Therapeutics, Inc ... - The Voice Registrar
07/14/16 07:30 AMBioMarin to Host Second Quarter 2016 Financial Results Conference Call and Webcast on Thursday, August 4 at 4:30pm ET - [GlobeNewswire] - SAN RAFAEL, Calif., July 14, 2016-- BioMarin Pharmaceutical Inc. today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on ...
07/13/16 10:39 AMBiotech: 'We Would Not Be Surprised to See Volatility Continue' -
07/12/16 07:01 AMLeading stocks in today's market: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - Twin County News
07/11/16 02:52 PMWere Analysts Bullish BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) This Week? - Consumer Eagle
07/11/16 02:52 PMHC Stocks Alerts: AstraZeneca plc (ADR) (NYSE:AZN), BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - share market updates (press release)
07/11/16 02:52 PMNoteworthy Analysts Suggestions: Rock Creek Pharmaceuticals, Inc. (PNK:RCPI) , BioMarin Pharmaceutical Inc ... - Street Updates
07/11/16 07:45 AMCompany Stock Focus for BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Which Way Will Shares Head? - Press Telegraph
07/10/16 02:49 PMStock Performance Rundown on: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - Press Telegraph
07/10/16 07:35 AMStock Performance to Track: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - News Oracle
07/09/16 02:46 PMOption Market: BioMarin Pharmaceutical Inc. Risk Hits An Elevated Level - CML News
07/09/16 02:46 PMOption Market: BioMarin Pharmaceutical Inc. Risk Hits An Elevated Level - CML News
07/09/16 09:40 AMWhy BioMarin's Shares Tumbled 11% in June -
07/09/16 09:40 AMWhy BioMarin's Shares Tumbled 11% in June -
07/09/16 08:55 AMBMRN Crosses Above Key Moving Average Level
07/08/16 09:28 AMCatabasis' DMD Drug in Phase II Open-Label Extension Study -
07/07/16 08:08 PMMedivation Bidders Will Have To Price In Talazoparib; BMO Sees $68-$76 Takeout Price
07/07/16 08:08 PMAhead of Friday's employment report, stocks struggled, but this trio soared
07/07/16 06:22 PMWhy BioMarin Pharmaceutical Inc. (BMRN), Western Digital Corp (WDC) and WhiteWave Foods Co (WWAV) Are 3 of Today’s Best Stocks - <p><a rel="nofollow" href="http://investorplace.com">InvestorPlace</a><a rel="nofollow" href="http://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>Takeover talk and improved earnings guidance made BMRN, WDC and WWAV three of Thursday's best performers.</p> <p>The post <a rel="nofollow" href="http://investorplace.com/2016/07/biomarin-pharmaceutical-inc-bmrn-western-digital-corp-wdc-whitewave-foods-co-wwav-3-todays-best-stocks/">Why BioMarin Pharmaceutical Inc. (BMRN), Western Digital Corp (WDC) and WhiteWave Foods Co (WWAV) Are 3 of Today’s Best Stocks</a> appeared first on <a rel="nofollow" href="http://investorplace.com">InvestorPlace</a>.</p>
07/07/16 04:52 PMWhy AVG Technologies, EZCorp, and BioMarin Pharmaceutical Jumped Today - On a quiet day for the markets, these stocks stood out. Find out why.
07/07/16 10:48 AMBuzz Stocks: PepsiCo, Inc., BioMarin Pharmaceutical Inc., and Second Sight Medical Products Inc - Schaeffers Research (blog)
07/07/16 10:35 AMBioMarin (BMRN) Stock Soars on Takeover Speculation -
07/07/16 09:58 AMSmaller-Cap And Oil ETFs Are Feeling The Love As Stocks Rebound -
07/06/16 02:57 PMStock Rating Watch and Earnings Insight for BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - Press Telegraph
07/06/16 02:57 PMBroker Outlook For BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - Fiscal Standard
07/06/16 02:57 PMA look at a High Market Cap Stock: BioMarin Pharmaceutical Inc., BMRN - The Daily Leicester
07/05/16 07:37 AMHC Stocks Midpoint: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Catalyst Biosciences Inc (NASDAQ:CBIO) - share market updates (press release)

Social

About BioMarin Pharmaceutical

BioMarin Pharmaceutical logoBioMarin Pharmaceutical Inc. (BioMarin) develops and commercializes pharmaceuticals for various diseases and medical conditions. The Company's product portfolio consists of approximately five approved products, and multiple clinical and pre-clinical product candidates. Its approved products include Vimizim (elosulfase alpha), Naglazyme (galsulfase), Kuvan (sapropterin dihydrochloride), Aldurazyme (laronidase) and Firdapse (amifampridine phosphate). Its products in clinical development include Kyndrisa, Pegvaliase, Reveglucosidase alfa, Vosoritide (formerly BMN 111), Cerliponase alfa, BMN 044, BMN 045, BMN 053 and BMN 270. Vimizim is an enzyme replacement therapy for the treatment of mucopolysaccharidosis type IV (MPS IV A). Naglazyme is a recombinant form of N-acetylgalactosamine 4-sulfatase (arylsulfatase B) indicated for patients with mucopolysaccharidosis VI (MPS VI). Kuvan is a synthetic oral form of 6R-BH4 indicated for patients with phenylketonuria (PKU).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: BMRN
  • CUSIP: 09061G10
Key Metrics:
  • Previous Close: $93.36
  • 50 Day Moving Average: $84.90
  • 200 Day Moving Average: $83.66
  • P/E Ratio: N/A
  • P/E Growth: -1.73
  • Market Cap: $15.19B
  • Beta: 0.98
  • Current Year EPS Consensus Estimate: $-2.18 EPS
  • Next Year EPS Consensus Estimate: $-1.38 EPS
Additional Links:
BioMarin Pharmaceutical (NASDAQ:BMRN) Chart for Saturday, July, 23, 2016